CD24 and cancer: Its overexpression during cancer progression and its prognostic significance have been reported for many types of cancer including breast, colorectal, gastric, lung, ovarian, pancreatic, and prostate cancers, supporting the usefulness of CD24 as a cancer marker for diagnosis and prognosis [6–10].